Interferon-γ constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition

Blood

Volumn 87, Issue 10, 1996, Pages 4149-4157

  Selleri, Carmine ^a   Maciejewski, Jaroslaw P ^a,b   Sato, Tadatsugu ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GAMMA INTERFERON; MESSENGER RNA;

ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; BURST FORMING UNIT E; CELL CYCLE; CELL DEATH; CELL STRUCTURE; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE TRANSFER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON PRODUCTION; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL;

EID: 0029990271     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4149.bloodjournal87104149     Document Type: Article

References (57)

1. Hertzog PJ, Wright A, Harris G, Linnane AW, Mackay IR: Intermittent interferonemia and interferon responses in multiple sclerosis. Clin Immunol Immunopathol 58:18, 1991
2. Link J, Soderstrom M, Olsson T, Hojeberg B, Ljungdhal A, Link HZ: Increased TGF-β and IFN-γ in multiple sclerosis. Ann Neurol 36:379, 1994
3. Castano L, Eisenbarth GS: Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647, 1990
4. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773, 1988
5. Moutsopoulos HM, Hooks JJ: Interferon and autoimmunity. Clin Exp Rheum 1:85, 1983
6. Jacob CO: TNF-α and IFN-γ: Relevance for immune regulation and genetic predisposition to autoimmune disease. Semin Immunol 4:147, 1992
7. Zoumbos N, Gascon P, Djeu J, Young NS: Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci USA 82:188, 1985
8. Viale M, Merli A, Bacigalupo A: Analysis at the clonal level of T-cell phenotype and functions in severe aplastic anemia patients. Blood 78:1268, 1991
9. Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 85:3367, 1995
10. Zoumbos N, Gascon P, Trost S, Djeu J, Young N: Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257, 1985
11. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102, 1994
12. Nakao S, Yamaguchi M, Shiobara S: Interferon gamma gene expression in unstimulated bone marrow mononuclear cells predicts a response to cyclosporine therapy in aplastic anemia. Blood 79:2532, 1992
13. Nisticò A, Young NS: γ-Interferon gene expression in the bone marrow of patients with acquired aplastic anemia. Ann Intern Med 120:463, 1994
14. Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY: The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and from patients with leukemia: Synergism of tumor necrosis factor and interferon-γ. J Immunol 136:4487, 1986
15. Raefsky EL, Platanias LC, Zoumbos NC, Young NS: Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol 135:2507, 1985
16. Snoek HV, Van Bockstaele DR, Nys G, Lenjou M, Lardon F, Haenem L, Rodrigus I, Peetermans ME, Berneman ZN: Interferon-γ selectively inhibits primitive CD34+CD38- and not mature CD34+CD38+ human hematopoietic progenitor cells. J Exp Med 180:1177, 1994
17. Verhoef GE, Schouwer P, Ceuppens JL, Van Damme JO, Goossens W, Boogaerts MA: Measurement of serum cytokine levels in patients with myelodysplastic syndrome. Leukemia 6:1268, 1992
18. Akashi K, Hayashi S, Gondo H, Mizuno SI, Tamura K, Yamasaki K, Shibuya T, Uike N, Okamura T, Miyamoto T, Niho Y: Involvement of interferon-gamma, and macrophage colony-stimulating factor in pathogenesis of hemophagocytic lymphohistiocytosis in adults. Br J Haematol 87:243, 1994
19. Torok-Storb B, Johnson G, Bowden R, Storb R: Gamma-interferon in aplastic anemia: Inability to detect significant levels in sera or demonstrate hematopoietic suppressing activity. Blood 69:629, 1987
20. + hematopoietic progenitor cells. Blood 79:2628, 1992
21. Kawano Y, Takaue Y, Hirao A, Abe T, Saito SI, Matsunaga K, Watanabe T, Hirose M, Ninomiya T, Kuroda Y, Yokobayashi A, Asano S: Synergistic effect of recombinant interferon-gamma and interleukin-3 on the growth of immature human hematopoietic progenitors. Blood 77:2118, 1991
22. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU: Clinical toxicity of interferons in cancer patients. J Clin Oncol 4:234, 1986
23. Aulitzky WE, Tilg H, Vogel W, Aulitzky W, Berger M, Gastl G, Herold M, Huber C: Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2. Ann Hematol 62:25, 1991
24. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells culture at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
25. Juneja HS, Gardner FH: Functionally abnormal marrow stromal cells in aplastic anemia. Exp Hematol 13:194, 1985
26. Bacigalupo A, Figari O, Tong J, Piaggio G, Miceli S, Frassoni F, Caciagli P, Badolati G, Marmont AM: Long-term marrow culture in patients with aplastic anemia compared with marrow transplant recipients and normal controls. Exp Hematol 20:425, 1992
27. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anemia: Analysis of stromal cell function in long-term marrow cultures. Blood 84:3685, 1994
28. Hotta T, Kato T, Maeda H, Yamao H, Yamada H, Saito H: Functional changes in marrow stromal cells in aplastic anemia. Acta Haematol 74:65, 1985
29. Entringer MA, Robinson WA, Drebing CJ: Colony stimulating activity in normal human serum tested against human bone marrow. Exp Hematol 8:1232, 1980
30. Marsh JCW, Chang J, Testa NG, Hows JM, Dexter TM: In vitro assesssment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 78:258, 1991
31. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM: Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 74:1563, 1989
32. Civin CJ, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH: Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell suface antigen defined by monoclonal antibody raised against KG-1a cells. J Immunol 133:157, 1984
33. Zoumbos NC, Baranski B, Young NS: Different hematopoietic growth factors have different capacity in overcoming the in vitro interferon gamma induced suppression of bone marrow progenitor cells. Eur J Hematol 44:282, 1990
34. Selleri C, Sato T, Andersen S, Young N, Maciejewski J: Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 165:538, 1995
35. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cells activators and inhibitory role of TGF-β. Blood 75:96, 1990
36. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110, 1991
37. Sieff CA, Niemeyer CM, Mentzer SJ, Faller D: Interleukin-1, tumor necrosis factor, and the production of colony stimulating factors by cultured mesenchymal cells. Blood 72:1316, 1988
38. Quesenberry P, Alberico T, Song ZX, Donowitz G, Stewart M, Gualtieri R, Boswell S, McGrath E, Kleeman E, Baber G: Studies on the regulation of hemopoiesis. Exp Hematol 13:43, 1985
39. Testa NG, Dexter TM: The biology of long-term bone marrow cultures and its application to bone marrow transplantation. Cur Opin Oncol 3:272, 1991
40. Greenberger JS: The hematopoietic microenvironment. Crit Rev Oncol Hematol 11:65, 1991
41. Gordon MY, Riley GP, Watt SM, Greaves MF: Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403, 1987
42. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM: Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis. Nature 332:376, 1988
43. Flanagan JG, Chan DC, Leder P: Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant. Cell 64:1025, 1991
44. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs S, Martin FH, Williams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
45. Brunner G, Metz C, Nguyen H, Gabrilove J, Patel SR, Davitz MA, Rifkin DB, Wilson EL: An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood 83:2115, 1994
46. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M, Yamamura KI: Chronic active hepatitis in transgenic mice expressing interferon-μ in the liver. Proc Natl Acad Sci USA 91:614, 1994
47. Roodman GD, Bird A, Hutzler D, Montgomery W: Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 15:928, 1987
48. Broxmeyer HE: Biomolecule-cell interaction on the regulation of myelopoiesis. Int J Cell Cloning 4:378, 1986
49. Broxmeyer HE, Williams DE, Lu L, Vadham S, Cooper S, Bicknell D, Ralph P, Guttermann J, Tricot G: Biomolecules associated with suppression of myelopoesis in normal conditions and during myeloid leukemia and other related disorders, in Najman A, Guigon M, Gorin NG, Mary JY (eds): The Inhibitors of Hematopoiesis (ed 162). Paris, France, INSERM, 1987, p 139
50. Hanninen A, Jalkanen S, Saimi M, Tokkanen S, Nikolakaros G, Simell O: Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 90:19091, 1992
51. Pukel C, Baquerizo H, Rabinovitch A: Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 37:133, 1988
52. Hooks JJ, Chan CC, Detrick B: Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci 29:1444, 1988
53. Katevas P, Maciejewski J, Sorrentino B, Young NS: Increased expression of TNF-beta in patients with aplastic anemia. Blood 82:345a, 1993 (abstr, suppl 1)
54. Maciejewski J, Liu J, Green S, Walsh C, Plumb M, Young NS: Expression of a stem cell inhibitor (SCI/LD78) gene in patients with bone marrow failure. Exp Hematol 20:1112, 1992
55. + human marrow cells is induced by interferon-gamma and tumor necrosis factor-α and potentiates hematopoietic suppression in vitro. Blood 85:3183, 1995
56. Maciejewski JP, Anderson S, Katevas P, Young NS: Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 87:227, 1994
57. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 265:528, 1994